Glycine

Glycine

SCHEMBL391786

NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O.NCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLRA1 P23415 1/20 1.00
SLC6A9 P48067 1/20 1.00
OR51E2 Q9H255 1/20 1.00
GABRR1 P24046 4/20 0.53
LMNA P02545 5/20 0.47
TSHR P16473 4/20 0.47
THRB P10828 3/20 0.47
BLM P54132 2/20 0.47
KMT2A Q03164 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
GABRR3 A8MPY1 1/20 0.47
GABRP O00591 1/20 0.47
GABRD O14764 1/20 0.47
HDAC3 O15379 1/20 0.47
GABBR2 O75899 1/20 0.47
CYP1A2 P05177 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRB1 P18505 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycine SCHEMBL30070584 1.00
Glycine SCHEMBL3640989 1.00 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL30179260 1.00
Glycine SCHEMBL2116443 1.00
Glycine SCHEMBL6163 1.00
Glycine SCHEMBL391027 1.00 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL13169653 1.00
Glycine SCHEMBL6675874 1.00 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL93765 1.00 GLRA1 (1.00) GLRA1SLC6A9OR51E2GABRR1LMNA
Glycine SCHEMBL29910347 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2030 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111778169-B Method for improving in vitro protein synthesis efficiency 康码(上海)生物科技有限公司 2023-02-10 CN claimed
CN-101165070-B A series of fusion protein with dual biological activity and medical treatment thereof BO YU 2010-12-08 CN claimed
CN-1325649-C Gene recombinant human cytomegalovirus fusion protein pp150/MDBP, preparation process and application thereof SHANDONG MEDICINAL BIOTECHNOLO (CN) 2007-07-11 CN claimed
EP-1615998-A4 PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS BASF PLANT SCIENCE GMBH (DE) 2007-06-13 EP claimed
CN-1763203-A Gene recombinant human cytomegalovirus fusion protein pp150/MDBP, preparation process and application thereof SHANDONG MEDICINAL BIOTECHNOLO (CN) 2006-04-26 CN claimed
EP-1615998-A2 PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS BASF Plant Science GmbH (DE) 2006-01-18 EP claimed
WO-2004092349-A2 PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS BASF PLANT SCIENCE GMBH (DE) 2004-10-28 WO claimed
EP-1379658-A2 ANTIMICROBIAL PEPTIDES AND METHODS OF USE PIONEER HI-BRED INTERNATIONAL, INC. (US) 2004-01-14 EP claimed
EP-1307479-A2 HERBICIDE TARGET GENES AND METHODS Syngenta Participations AG (CH) 2003-05-07 EP claimed
WO-2001070980-A9 ISOLATED G-PROTEIN COUPLED RECEPTORS, NUCLEIC ACID MOLECULES ENCODING GPCR PROTEINS, AND USES THEREOF AS INSECTICIDAL TARGETS PE CORP NY (US) 2003-01-16 WO claimed
WO-2002026246-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYNUCLEOTIDES ENCODING A RAF PROTEIN GSF-FORSCHUNGSZENTRUM FÜR UMWELT UND GESUNDHEIT, GMBH (DE) 2002-04-04 WO claimed
WO-2002022821-A2 ANTIMICROBIAL PEPTIDES AND METHODS OF USE PIONEER HI-BRED INTERNATIONAL, INC. (US) 2002-03-21 WO claimed
US-6355462-B1 NUCLEOTIDE SEQUENCES CODING ENZYMATIC POLYPEPTIDE FOR USE IN THE GENERATION OF DISEASE RESISTANT PLANTS E.I. DU PONT DE NEMOURS AND COMPANY 2002-03-12 US claimed
WO-2002000696-A2 HERBICIDE TARGET GENES AND METHODS SYNGENTA PARTICIPATIONS AG (CH) 2002-01-03 WO claimed
US-5717065-A Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen THE SCRIPPS RESEARCH INSTITUTE (US) 1998-02-10 US claimed
CN-115038722-B Antibodies against KLK5 UCB biopharmaceutical Co.,Ltd. (BE) 2026-05-26 CN disclosed
CN-122070138-A Compositions and methods for expressing EGFR 瑞普利科特生物科学公司 2026-05-19 CN disclosed
WO-1990015153-A1 A METHOD FOR THE DETECTION OF ANTI-STREPTOKINASE ANTIBODIES GEORGETOWN UNIVERSITY (US) 1990-12-13 WO disclosed
WO-1988008164-A1 COMPUTER DESIGNED STABILIZED PROTEINS AND METHOD FOR PRODUCING SAME GENEX CORPORATION (US) 1988-10-20 WO disclosed
WO-1988008165-A1 COMPUTER BASED METHOD FOR PROTEIN ENGINEERING GENEX CORPORATION (US) 1988-10-20 WO disclosed